Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01110005 · ClinicalTrials.gov registry record · NA
A Trial of Intravenous Fluids During Labor
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 318
- Enrollment target
NCT01110005: Completed NA study, sponsored by Milton S. Hershey Medical Center.
NCT01110005 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 318 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01110005, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 318 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if intrapartum use of a glucose-containing solution will improve the outcomes in pregnant women and their babies.
Primary Outcome
Compare c-section rates between the D5LR and LR treatment groups
Interventions
- OTHER D5 Lactated Ringer's Solution (D5LR)
- OTHER Lactated Ringer's Solution (LR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2010-04 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01110005 record still lists
NCT01110005 is an interventional study that assigns participants to a tested intervention. The registered 318 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which D5 Lactated Ringer's Solution (D5LR) is the first listed.
NCT01110005 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01110005 about?
NCT01110005 is a clinical study titled "A Trial of Intravenous Fluids During Labor". The purpose of this study is to determine if intrapartum use of a glucose-containing solution will improve the outcomes in pregnant women and their babies.
What is the current status of trial NCT01110005?
This trial is currently completed. It is a NA study. The enrollment target is 318 participants. The study started on 2010-04. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01110005?
The interventions under investigation include: D5 Lactated Ringer's Solution (D5LR) (OTHER), Lactated Ringer's Solution (LR) (OTHER).
Who is sponsoring clinical trial NCT01110005?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01110005's enrollment target sits among peer trials
318 321st of 2000 higher than 1,680 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05488340 · 318 participants · Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
- NCT05675735 · 318 participants · NA
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
- NCT05895786 · 318 participants · Phase 3
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NCT06051617 · 318 participants · Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia